tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Denys-Drash Syndrome D030321 1 associated lipids
Hypophosphatemia D017674 1 associated lipids
Moyamoya Disease D009072 1 associated lipids
Latent Tuberculosis D055985 1 associated lipids
Leukoplakia D007971 1 associated lipids
Oculomotor Nerve Diseases D015840 1 associated lipids
Scorpion Stings D065008 1 associated lipids
Esophageal Perforation D004939 1 associated lipids
Mediastinitis D008480 2 associated lipids
Coproporphyria, Hereditary D046349 1 associated lipids
Ileus D045823 3 associated lipids
Rectal Diseases D012002 1 associated lipids
Angiolymphoid Hyperplasia with Eosinophilia D000796 1 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Smoter P et al. Risk factors of acute renal failure after orthotopic liver transplantation: single-center experience. 2014 Transplant. Proc. pmid:25380918
Lerut JP et al. Is minimal, [almost] steroid-free immunosuppression a safe approach in adult liver transplantation? Long-term outcome of a prospective, double blind, placebo-controlled, randomized, investigator-driven study. 2014 Ann. Surg. pmid:25379858
Wu Y et al. Increased macrophage activation inhibited by tacrolimus in the kidney of diabetic rats. 2014 Nephron Exp. Nephrol. pmid:25376933
Levitsky J and Feng S Sirolimus and mTOR inhibitors in liver transplantation: the wheel has come full circle. 2014 Am. J. Transplant. pmid:24620373
Catalano G et al. Everolimus-based immunosuppression in a case of ABO-incompatible liver transplantation with calcineurin inhibitor-related posterior occipital syndrome. 2014 Transpl. Int. pmid:24606320
Muhetaer G et al. Clinical significance of peripheral blood lymphocyte sensitivity to glucocorticoids for the differentiation of high-risk patients with decreased allograft function after glucocorticoid withdrawal in renal transplantation. 2014 Clin Ther pmid:25037282
Moss MC et al. Lithium use for bipolar disorder post renal transplant: is mood stabilization without toxicity possible? 2014 Transplantation pmid:24492429
Lipson EJ et al. Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma. 2014 J. Clin. Oncol. pmid:24493726
Hinchliffe E et al. Therapeutic drug monitoring of ciclosporin A and tacrolimus in heart lung transplant patients using dried blood spots. 2014 Ann. Clin. Biochem. pmid:23939194
Pulsipher MA et al. The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial. 2014 Blood pmid:24497539
Verma M et al. Impact of single immunosuppressive drug withdrawal on lymphocyte immunoreactivity. 2014 J. Surg. Res. pmid:24485875
El-Sheikh AA et al. Renal glucuronidation and multidrug resistance protein 2-/ multidrug resistance protein 4-mediated efflux of mycophenolic acid: interaction with cyclosporine and tacrolimus. 2014 Transl Res pmid:24486136
Carr L et al. Calcineurin activity assay measurement by liquid chromatography-tandem mass spectrometry in the multiple reaction monitoring mode. 2014 Clin. Chem. pmid:24281780
Rehman S et al. Effect of different tacrolimus levels on early outcomes after kidney transplantation. 2014 Ann. Transplant. pmid:24509826
Backes AN et al. Effects of tacrolimus and insulin in a liver regeneration model in growing animals with portal vein stenosis: immunohistochemical and molecular studies. 2014 Pediatr. Surg. Int. pmid:24468714
Xie M et al. Tacrolimus-related seizure after pediatric liver transplantation--a single-center experience. 2014 Pediatr Transplant pmid:24283660
Tavira B et al. [Pharmacogenetics of tacrolimus: from bench to bedside?]. 2014 Nefrologia pmid:24463861
Qin XL et al. In vivo to in vitro effects of six bioactive lignans of Wuzhi tablet (Schisandra sphenanthera extract) on the CYP3A/P-glycoprotein-mediated absorption and metabolism of tacrolimus. 2014 Drug Metab. Dispos. pmid:24195812
Qin XL et al. Effect of Tacrolimus on the pharmacokinetics of bioactive lignans of Wuzhi tablet (Schisandra sphenanthera extract) and the potential roles of CYP3A and P-gp. 2014 Phytomedicine pmid:24462213
Asrani SK et al. De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. 2014 Am. J. Transplant. pmid:24456026
Nevers W et al. Safety of tacrolimus in pregnancy. 2014 Can Fam Physician pmid:25316742
Oellerich M et al. Use of graft-derived cell-free DNA as an organ integrity biomarker to reexamine effective tacrolimus trough concentrations after liver transplantation. 2014 Ther Drug Monit pmid:24452066
Wang J et al. Molecular mechanisms of FK506-induced hypertension in solid organ transplantation patients. 2014 Chin. Med. J. pmid:25316243
Khorrami A et al. Tacrolimus ameliorates functional disturbances and oxidative stress in isoproterenol-induced myocardial infarction. 2014 Daru pmid:25312839
Boran M et al. Determining renal resistive and pulsatility indexes long-term after kidney transplantation in kidney transplant recipients on cyclosporine a-, tacrolimus-, or sirolimus-based regimens. 2014 Transplant. Proc. pmid:24935296
Fuchs U et al. Clinical outcome in heart transplant recipients receiving everolimus in combination with dosage reduction of the calcineurin inhibitor cyclosporine A or tacrolimus. 2014 Transpl. Immunol. pmid:24932812
Motomura H et al. Inhibitory effect of tacrolimus on progression of joint damage in patients with rheumatoid arthritis. 2014 Int J Rheum Dis pmid:24251619
Han N et al. Population pharmacokinetic-pharmacogenetic model of tacrolimus in the early period after kidney transplantation. 2014 Basic Clin. Pharmacol. Toxicol. pmid:24238261
Basu B Ofatumumab for rituximab-resistant nephrotic syndrome. 2014 N. Engl. J. Med. pmid:24670185
Fukushima A et al. Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement. 2014 Br J Ophthalmol pmid:24695688
Yasukochi Y et al. Reduction of serum TARC levels in atopic dermatitis by topical anti-inflammatory treatments. 2014 Asian Pac. J. Allergy Immunol. pmid:25268342
Cho A et al. Calcineurin signaling regulates neural induction through antagonizing the BMP pathway. 2014 Neuron pmid:24698271
Zhang L et al. Ambrisentan improves the outcome of rats with liver transplantation partially through reducing nephrotoxicity. 2014 Eur Rev Med Pharmacol Sci pmid:25268107
Donnadieu B et al. Central retinal vein occlusion-associated tacrolimus after liver transplantation. 2014 Transplantation pmid:25955343
Rangel EB Tacrolimus in pancreas transplant: a focus on toxicity, diabetogenic effect and drug-drug interactions. 2014 Expert Opin Drug Metab Toxicol pmid:25255841
Hirai F et al. Impact of CYP3A5 genetic polymorphisms on the pharmacokinetics and short-term remission in patients with ulcerative colitis treated with tacrolimus. 2014 J. Gastroenterol. Hepatol. pmid:24033383
Al-Harbi NO et al. Protection against tacrolimus-induced cardiotoxicity in rats by olmesartan and aliskiren. 2014 Toxicol. Mech. Methods pmid:25199528
Wilusz M et al. Effect of immunosuppressive therapy on the serum fatty acids of phospholipids fraction in patients after heart transplantation. 2014 Transplant. Proc. pmid:25380928
Notaro E et al. Dose conversion factor between cyclosporine and tacrolimus in pediatric heart transplant recipients. 2014 J. Heart Lung Transplant. pmid:24854566
Lan CC et al. Tacrolimus abrogates TGF-β1-induced type I collagen production in normal human fibroblasts through suppressing p38MAPK signalling pathway: implications on treatment of chronic atopic dermatitis lesions. 2014 J Eur Acad Dermatol Venereol pmid:23301526
Burroughs LM et al. Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial. 2014 Biol. Blood Marrow Transplant. pmid:25196857
Parks AC et al. Long-term clearance of linear porokeratosis with tacrolimus, 0.1%, ointment. 2014 JAMA Dermatol pmid:24553841
Xu C et al. Tacrolimus reversibly reduces insulin secretion, induces insulin resistance, and causes islet cell damage in rats. 2014 Int J Clin Pharmacol Ther pmid:24755137
Ichinose K et al. [Rare case of systemic lupus erythematosus with encapsulating peritoneal sclerosis during hemodialysis]. 2014 Nihon Jinzo Gakkai Shi pmid:24730352
Werk AN et al. Identification and characterization of a defective CYP3A4 genotype in a kidney transplant patient with severely diminished tacrolimus clearance. 2014 Clin. Pharmacol. Ther. pmid:24126681
Carcas-Sansuán AJ et al. Conversion from Prograf to Advagraf in stable paediatric renal transplant patients and 1-year follow-up. 2014 Pediatr. Nephrol. pmid:23907143
Guy-Viterbo V et al. Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach. 2014 Pharmacogenomics pmid:25141896
Cavalli RC et al. Analysis of the histology of the scar bladder and biochemical parameters of rats with a solitary kidney undergoing immunosuppression with tacrolimus. 2014 Acta Cir Bras pmid:25140592
Zhao WY et al. Single kidneys transplanted from small pediatric donors less than 15 kilograms into pediatric recipients. 2014 Transplantation pmid:25955345
Mabe S et al. Detecting protein-protein interactions based on kinase-mediated growth induction of mammalian cells. 2014 Sci Rep pmid:25135216
Sol Fustiñana M et al. Protein degradation by ubiquitin-proteasome system in formation and labilization of contextual conditioning memory. 2014 Learn. Mem. pmid:25135196
García-García B et al. Frosch' surface microscopy score for the assessment of steroid-induced atrophy. 2014 Arch. Dermatol. Res. pmid:24402286
Gionchetti P and Rizzello F IBD. Sequential rescue therapy in steroid-refractory ulcerative colitis. 2014 Nat Rev Gastroenterol Hepatol pmid:25023033
Van der Hauwaert C et al. Expression profiles of genes involved in xenobiotic metabolism and disposition in human renal tissues and renal cell models. 2014 Toxicol. Appl. Pharmacol. pmid:25036895
Shen T et al. A modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure. 2014 HBPD INT pmid:25100124
Zivčić-Ćosić S et al. Immune reactivity of renal transplant recipients receiving interleukin-2 receptor antagonists during the early posttransplant period. 2014 Int Urol Nephrol pmid:23515930
Wang B et al. Multifaceted interaction of the traditional Chinese medicinal herb Schisandra chinensis with cytochrome P450-mediated drug metabolism in rats. 2014 J Ethnopharmacol pmid:25091466
Hadjipanagi D et al. Genetic polymorphisms in warfarin and tacrolimus-related genes VKORC1, CYP2C9 and CYP3A5 in the Greek-Cypriot population. 2014 BMC Res Notes pmid:24593903
Bao J and Liang H Tacrolimus-induced permanent asymptomatic pontine myelinolysis after liver transplantation. 2014 Intern. Med. pmid:25088893
Helenius-Hietala J et al. Oral mucosal health in liver transplant recipients and controls. 2014 Liver Transpl. pmid:24142471
Thapa RK and Yoo BK Evaluation of the effect of tacrolimus-loaded liquid crystalline nanoparticles on psoriasis-like skin inflammation. 2014 J Dermatolog Treat pmid:23210668
Viecelli A et al. Diagnostic and management dilemma of a pancreas-kidney transplant recipient with aplastic anaemia. 2014 BMJ Case Rep pmid:25257886
Jaksch P et al. Alemtuzumab in lung transplantation: an open-label, randomized, prospective single center study. 2014 Am. J. Transplant. pmid:25039364
Segarra-Medrano A et al. Evolution of antibody titre against the M-type phospholipase A2 receptor and clinical response in idiopathic membranous nephropathy patients treated with tacrolimus. 2014 Nefrologia pmid:25036063
Bax K et al. Rapid resolution of tacrolimus intoxication-induced AKI with a corticosteroid and phenytoin. 2014 Ann Pharmacother pmid:25104567
Marits P et al. Evaluation of T and B lymphocyte function in clinical practice using a flow cytometry based proliferation assay. 2014 Clin. Immunol. pmid:24909732
Uesugi M et al. Impact of cytochrome P450 3A5 polymorphism in graft livers on the frequency of acute cellular rejection in living-donor liver transplantation. 2014 Pharmacogenet. Genomics pmid:24911663
Di Stasio D et al. Oral lichen planus: a narrative review. 2014 Front Biosci (Elite Ed) pmid:24896212
Levinger E et al. Topical 0.03% tacrolimus for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis. 2014 Graefes Arch. Clin. Exp. Ophthalmol. pmid:24696044
Nikitin AV [Mechanisms of nephrotoxic action of immunodepressants, calcineurine inhibitors]. 2014 Antibiot. Khimioter. pmid:25051716
GoriaÄ­nov VA et al. [Effect of tacrolimus on the results of living related kidney donor transplantation]. 2014 Ter. Arkh. pmid:25095659
Shilpa PS et al. Topical tacrolimus in the management of oral lichen planus: literature review. 2014 J Calif Dent Assoc pmid:25080722
Dessilly G et al. ABCB1 1199G>A genetic polymorphism (Rs2229109) influences the intracellular accumulation of tacrolimus in HEK293 and K562 recombinant cell lines. 2014 PLoS ONE pmid:24621983
Falconer SJ et al. Conversion from twice-daily to once-daily tacrolimus in simultaneous pancreas-kidney transplant patients. 2014 Transplant. Proc. pmid:24935313
Terada Y et al. Intestinal P-glycoprotein expression is multimodally regulated by intestinal ischemia-reperfusion. 2014 J Pharm Pharm Sci pmid:24934555
Goring SM et al. A network meta-analysis of the efficacy of belatacept, cyclosporine and tacrolimus for immunosuppression therapy in adult renal transplant recipients. 2014 Curr Med Res Opin pmid:24628478
Mai S et al. In vitro and in vivo release characteristics of Tacrolimus (FK506) from an episcleral drug-delivery implant. 2014 J Ocul Pharmacol Ther pmid:24933028
Nomura H et al. A patient with lupus miliaris disseminatus faciei treated successfully with a combination of oral metronidazole and topical tacrolimus. 2014 J. Dermatol. pmid:24931738
Liu Z et al. Tacrolimus-based versus cyclosporine-based immunosuppression in hepatitis C virus-infected patients after liver transplantation: a meta-analysis and systematic review. 2014 PLoS ONE pmid:25198195
Katayama M et al. Preliminary study of interaction of clarithromycin with tacrolimus in cats. 2014 J. Vet. Med. Sci. pmid:25099737
Shihab F et al. Focus on mTOR inhibitors and tacrolimus in renal transplantation: pharmacokinetics, exposure-response relationships, and clinical outcomes. 2014 Transpl. Immunol. pmid:24861504
Almeida-Paulo GN et al. Limited sampling strategies for tacrolimus exposure (AUC0-24) prediction after Prograf(®) and Advagraf(®) administration in children and adolescents with liver or kidney transplants. 2014 Transpl. Int. pmid:24861353
Chamienia A et al. Open prospective study to evaluate cardiovascular risk factors and renal function in 2 dosage regimens of tacrolimus combined with mycophenolate mofetil and steroids in renal transplant patients: 5-year results. 2014 Transplant. Proc. pmid:25380901
Doren EL and Aya-ay ML Pyoderma gangrenosum following breast reduction: treatment with topical tacrolimus and steroids. 2014 Aesthet Surg J pmid:24448967
Lee CM et al. Monotherapy with tacrolimus for heart and liver transplant: a case report. 2014 Transplant. Proc. pmid:24767396
Lin YH and Pratt MR A dual small-molecule rheostat for precise control of protein concentration in Mammalian cells. 2014 Chembiochem pmid:24615791
Abe T et al. Risk factors for development of new-onset diabetes mellitus and progressive impairment of glucose metabolism after living-donor liver transplantation. 2014 Transplant. Proc. pmid:24767367
Mita A et al. Optimal initial dose of orally administered once-daily extended-release tacrolimus following intravenous tacrolimus therapy after liver transplantation. 2014 Transplant. Proc. pmid:24767351
Hashi S et al. Assessment of four methodologies (microparticle enzyme immunoassay, chemiluminescent enzyme immunoassay, affinity column-mediated immunoassay, and flow injection assay-tandem mass spectrometry) for measuring tacrolimus blood concentration in Japanese liver transplant recipients. 2014 Transplant. Proc. pmid:24767342
Upadhyay V et al. Rapid and sensitive UPLC-MS-MS determination of tacrolimus in Wistar rats and human blood. 2014 J Chromatogr Sci pmid:23264321
Philipone E et al. Oral ulcerations as a sequela of tacrolimus and mycophenolate mofetil therapy. 2014 Oral Surg Oral Med Oral Pathol Oral Radiol pmid:25457894
Chen C et al. Rapid construction of a Bacterial Artificial Chromosomal (BAC) expression vector using designer DNA fragments. 2014 Plasmid pmid:25454071
Olson KA et al. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease. 2014 Pharmacotherapy pmid:24700567
Momohara S et al. Recent trends in orthopedic surgery aiming to improve quality of life for those with rheumatoid arthritis: data from a large observational cohort. 2014 J. Rheumatol. pmid:24692532
Lin Q et al. Pharmacological mobilization of endogenous stem cells significantly promotes skin regeneration after full-thickness excision: the synergistic activity of AMD3100 and tacrolimus. 2014 J. Invest. Dermatol. pmid:24682043
Díaz-García C et al. Pregnancy after allogeneic uterus transplantation in the rat: perinatal outcome and growth trajectory. 2014 Fertil. Steril. pmid:25439799
Tsunashima D et al. Assessment of tacrolimus absorption from the human intestinal tract: open-label, randomized, 4-way crossover study. 2014 Clin Ther pmid:24680768
Ibrahim O et al. The role of infliximab in the treatment of superficial granulomatous pyoderma of the head and neck. 2014 J. Am. Acad. Dermatol. pmid:25438004
Kraaij MD et al. Human monocytes produce interferon-gamma upon stimulation with LPS. 2014 Cytokine pmid:24680476
Sawamoto K et al. Mechanisms of lower maintenance dose of tacrolimus in obese patients. 2014 Drug Metab. Pharmacokinet. pmid:24670405